skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
0.2% Betamethasone Sodium Phosphate: A Multicenter, Randomized, Double-Masked Study to Compare Its Ocular Safety, Tolerability, and Efficacy to Vehicle in Cataract Surgery Subjects
Material Type:
Article
Add to My Research

0.2% Betamethasone Sodium Phosphate: A Multicenter, Randomized, Double-Masked Study to Compare Its Ocular Safety, Tolerability, and Efficacy to Vehicle in Cataract Surgery Subjects

Clinical ophthalmology (Auckland, N.Z.), 2023-08, Vol.17, p.2219-2230 [Peer Reviewed Journal]

2023 Hosseini et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023 Hosseini et al. 2023 Hosseini et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S419857 ;PMID: 37564159

Full text available

2
11th Excellence in Pediatrics Conference - 2019 Book of Abstracts
Material Type:
Article
Add to My Research

11th Excellence in Pediatrics Conference - 2019 Book of Abstracts

Cogent medicine, 2019-01, Vol.6 (1), p.1694205

2019 The Author(s). This open access article is distributed under a Creative Commons Attribution (CC-BY) 4.0 license. 2019 ;2019 The Author(s). This open access article is distributed under a Creative Commons Attribution (CC-BY) 4.0 license. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2331-205X ;EISSN: 2331-205X ;DOI: 10.1080/2331205X.2019.1694205

Full text available

3
11th International Congress on Psychopharmacology & 7th International Symposium on Child and Adolescent Psychopharmacology
Material Type:
Article
Add to My Research

11th International Congress on Psychopharmacology & 7th International Symposium on Child and Adolescent Psychopharmacology

Psychiatry and clinical psychopharmacology, 2019-08, Vol.29 (sup1), p.129-263 [Peer Reviewed Journal]

2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2019 ;2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2475-0573 ;EISSN: 2475-0581 ;DOI: 10.1080/24750573.2019.1608065

Full text available

4
12-Month Teriparatide Treatment Reduces New Vertebral Compression Fractures Incidence And Back Pain And Improves Quality Of Life After Percutaneous Kyphoplasty In Osteoporotic Women
Material Type:
Article
Add to My Research

12-Month Teriparatide Treatment Reduces New Vertebral Compression Fractures Incidence And Back Pain And Improves Quality Of Life After Percutaneous Kyphoplasty In Osteoporotic Women

Clinical interventions in aging, 2019-01, Vol.14, p.1693-1703 [Peer Reviewed Journal]

2019 Kong et al. ;COPYRIGHT 2019 Dove Medical Press Limited ;2019 Kong et al. 2019 Kong et al. ;ISSN: 1178-1998 ;ISSN: 1176-9092 ;EISSN: 1178-1998 ;DOI: 10.2147/CIA.S224663 ;PMID: 31631990

Full text available

5
1,3,4, Oxadiazole Compound A3 Provides Robust Protection Against PTZ-Induced Neuroinflammation and Oxidative Stress by Regulating N/[Florin]2-Pathway
Material Type:
Article
Add to My Research

1,3,4, Oxadiazole Compound A3 Provides Robust Protection Against PTZ-Induced Neuroinflammation and Oxidative Stress by Regulating N/[Florin]2-Pathway

Journal of inflammation research, 2021-12, Vol.14, p.7393 [Peer Reviewed Journal]

COPYRIGHT 2021 Dove Medical Press Limited ;ISSN: 1178-7031 ;EISSN: 1178-7031 ;DOI: 10.2147/JIR.S333451

Full text available

6
1,3,4, Oxadiazole Compound A3 Provides Robust Protection Against PTZ-Induced Neuroinflammation and Oxidative Stress by Regulating Nrf2 -Pathway
Material Type:
Article
Add to My Research

1,3,4, Oxadiazole Compound A3 Provides Robust Protection Against PTZ-Induced Neuroinflammation and Oxidative Stress by Regulating Nrf2 -Pathway

Journal of inflammation research, 2021-01, Vol.14, p.7393-7409 [Peer Reviewed Journal]

2021 Alvi et al. ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Alvi et al. 2021 Alvi et al. ;ISSN: 1178-7031 ;EISSN: 1178-7031 ;DOI: 10.2147/JIR.S333451 ;PMID: 35002275

Full text available

7
18F-FDG PET/MR Assessment of Pediatric Langerhans Cell Histiocytosis
Material Type:
Article
Add to My Research

18F-FDG PET/MR Assessment of Pediatric Langerhans Cell Histiocytosis

International journal of general medicine, 2021-10, Vol.14, p.6251-6259 [Peer Reviewed Journal]

2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Niu et al. 2021 Niu et al. ;ISSN: 1178-7074 ;EISSN: 1178-7074 ;DOI: 10.2147/IJGM.S327134 ;PMID: 34629891

Full text available

8
2021 EIP abstract book
Material Type:
Article
Add to My Research

2021 EIP abstract book

Cogent medicine, 2021-01, Vol.8 (1)

2021 The Author(s). This open access article is distributed under a Creative Commons Attribution (CC-BY) 4.0 license. 2021 ;2021 The Author(s). This open access article is distributed under a Creative Commons Attribution (CC-BY) 4.0 license. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2331-205X ;EISSN: 2331-205X ;DOI: 10.1080/2331205X.2021.2002558

Full text available

9
2023 EIP abstract book
Material Type:
Article
Add to My Research

2023 EIP abstract book

Cogent public health, 2023-12, Vol.10 (1) [Peer Reviewed Journal]

2023 Excellence in Pediatrics Institute. Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2770-7571 ;EISSN: 2770-7571 ;DOI: 10.1080/27707571.2023.2275942

Full text available

10
23-gauge pars plana vitrectomy for management of posteriorly dislocated crystalline lens
Material Type:
Article
Add to My Research

23-gauge pars plana vitrectomy for management of posteriorly dislocated crystalline lens

Clinical ophthalmology (Auckland, N.Z.), 2011-01, Vol.5 (default), p.1737-1743 [Peer Reviewed Journal]

2011. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2011 Cho and Chan, publisher and licensee Dove Medical Press Ltd 2011 ;ISSN: 1177-5483 ;ISSN: 1177-5467 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S22331 ;PMID: 22205834

Full text available

11
23-gauge vitrectomy assisted by combined endoscopy and a wide-angle viewing system for retinal detachment with severe penetrating corneal injury: a case report
Material Type:
Article
Add to My Research

23-gauge vitrectomy assisted by combined endoscopy and a wide-angle viewing system for retinal detachment with severe penetrating corneal injury: a case report

Clinical ophthalmology (Auckland, N.Z.), 2011-01, Vol.5 (default), p.1767-1770 [Peer Reviewed Journal]

2011. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2011 Morishita et al, publisher and licensee Dove Medical Press Ltd. 2011 ;ISSN: 1177-5483 ;ISSN: 1177-5467 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S25373 ;PMID: 22267909

Full text available

12
30-Day Potentially Preventable Hospital Readmissions In Older Patients: Clinical Phenotype And Health Care Related Risk Factors
Material Type:
Article
Add to My Research

30-Day Potentially Preventable Hospital Readmissions In Older Patients: Clinical Phenotype And Health Care Related Risk Factors

Clinical interventions in aging, 2019-11, Vol.14, p.1851-1858 [Peer Reviewed Journal]

2019 Calsolaro et al. ;COPYRIGHT 2019 Dove Medical Press Limited ;COPYRIGHT 2019 Dove Medical Press Limited ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Calsolaro et al. 2019 Calsolaro et al. ;ISSN: 1178-1998 ;ISSN: 1176-9092 ;EISSN: 1178-1998 ;DOI: 10.2147/CIA.S208572 ;PMID: 31806943

Full text available

13
360° ab-interno trabeculotomy in refractory primary open-angle glaucoma
Material Type:
Article
Add to My Research

360° ab-interno trabeculotomy in refractory primary open-angle glaucoma

Clinical ophthalmology (Auckland, N.Z.), 2019, Vol.13, p.161-168 [Peer Reviewed Journal]

COPYRIGHT 2019 Dove Medical Press Limited ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Sarkisian et al. This work is published and licensed by Dove Medical Press Limited 2019 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S189260 ;PMID: 30666087

Full text available

14
4-Octyl Itaconate Alleviates Lipopolysaccharide-Induced Acute Lung Injury in Mice by Inhibiting Oxidative Stress and Inflammation
Material Type:
Article
Add to My Research

4-Octyl Itaconate Alleviates Lipopolysaccharide-Induced Acute Lung Injury in Mice by Inhibiting Oxidative Stress and Inflammation

Drug design, development and therapy, 2020-01, Vol.14, p.5547-5558 [Peer Reviewed Journal]

2020 Li et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Li et al. 2020 Li et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S280922 ;PMID: 33364751

Full text available

15
4-week eicosapentaenoic acid-rich fish oil supplementation partially protects muscular damage following eccentric contractions
Material Type:
Article
Add to My Research

4-week eicosapentaenoic acid-rich fish oil supplementation partially protects muscular damage following eccentric contractions

Journal of the International Society of Sports Nutrition, 2021-03, Vol.18 (1), p.18-18 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1550-2783 ;EISSN: 1550-2783 ;DOI: 10.1186/s12970-021-00411-x ;PMID: 33648546

Full text available

16
5-(Bis(3-(2-hydroxyethyl)-1H-indol-2-yl)methyl)-2-hydroxybenzoic acid (BHIMHA): showing a strategy of designing drug to block lung metastasis of tumors
Material Type:
Article
Add to My Research

5-(Bis(3-(2-hydroxyethyl)-1H-indol-2-yl)methyl)-2-hydroxybenzoic acid (BHIMHA): showing a strategy of designing drug to block lung metastasis of tumors

Drug design, development and therapy, 2016-01, Vol.10 (Issue 1), p.711-721 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Gan et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S93570 ;PMID: 26937173

Full text available

17
5% Lidocaine-medicated plaster for the treatment of chronic peripheral neuropathic pain: complex regional pain syndrome and other neuropathic conditions
Material Type:
Article
Add to My Research

5% Lidocaine-medicated plaster for the treatment of chronic peripheral neuropathic pain: complex regional pain syndrome and other neuropathic conditions

Journal of pain research, 2016-01, Vol.9, p.763-770 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Calderón et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1178-7090 ;EISSN: 1178-7090 ;DOI: 10.2147/JPR.S113517 ;PMID: 27785090

Full text available

18
5-: showing a strategy of designing drug to block lung metastasis of tumors
Material Type:
Article
Add to My Research

5-: showing a strategy of designing drug to block lung metastasis of tumors

Drug design, development and therapy, 2016-01, Vol.10, p.711 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S93570

Full text available

19
7-Nitroindazole and its rapidly emerging role in opioid pain management and withdrawal
Material Type:
Article
Add to My Research

7-Nitroindazole and its rapidly emerging role in opioid pain management and withdrawal

Journal of blood medicine, 2012-01, Vol.3 (default), p.15-16 [Peer Reviewed Journal]

COPYRIGHT 2012 Dove Medical Press Limited ;COPYRIGHT 2012 Dove Medical Press Limited ;2012. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2012 Kapoor, publisher and licensee Dove Medical Press Ltd. 2012 ;ISSN: 1179-2736 ;EISSN: 1179-2736 ;DOI: 10.2147/JBM.S31988 ;PMID: 22629117

Full text available

20
8 hrs Safety Evaluation Of A Multi-Pressure Dial In Eyes With Glaucoma: Prospective, Open-Label, Randomized Study
Material Type:
Article
Add to My Research

8 hrs Safety Evaluation Of A Multi-Pressure Dial In Eyes With Glaucoma: Prospective, Open-Label, Randomized Study

Clinical ophthalmology (Auckland, N.Z.), 2019-10, Vol.13, p.1947-1953 [Peer Reviewed Journal]

2019 Samuelson et al. ;COPYRIGHT 2019 Dove Medical Press Limited ;COPYRIGHT 2019 Dove Medical Press Limited ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Samuelson et al. 2019 Samuelson et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S217736 ;PMID: 31631962

Full text available

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (8,948)

Refine My Results

Creation Date 

From To
  1. Before 1984  (17)
  2. 1984 To 1995  (10)
  3. 1996 To 2006  (88)
  4. 2007 To 2016  (3,591)
  5. After 2016  (5,581)
  6. More options open sub menu

Resource Type 

  1. Articles  (8,981)
  2. Reports  (305)
  3. Reviews  (1)
  4. More options open sub menu

Subject 

  1. Science & Technology  (7,611)
  2. Life Sciences & Biomedicine  (7,544)
  3. Original Research  (3,788)
  4. Review  (2,322)
  5. Care And Treatment  (2,152)
  6. Patients  (2,090)
  7. Health Aspects  (1,871)
  8. Ophthalmology  (1,830)
  9. Edema  (1,325)
  10. Medical Research  (1,259)
  11. Analysis  (1,207)
  12. Pharmacology & Pharmacy  (1,149)
  13. Humans  (1,094)
  14. Inflammation  (1,070)
  15. Surgery  (1,050)
  16. Medicine, Experimental  (1,021)
  17. Diabetes  (1,002)
  18. Risk Factors  (933)
  19. Case Report  (844)
  20. Drug Therapy  (787)
  21. More options open sub menu

Language 

  1. Japanese  (504)
  2. Norwegian  (9)
  3. French  (1)
  4. More options open sub menu

Searching Remote Databases, Please Wait